I believe the level of support for him in this year's vote may be significantly lower. Aside from Cortexa and Relief, both of which will be slow burn, there hasn't been any expansion into additional revenue-generating sectors. There have been no mergers or acquisitions either. It seems unwise to accumulate cash at this early stage of the business instead of utilizing it to propel the company forward and stay ahead of the competition. They should have bought out the competition by now.
VIT Price at posting:
33.0¢ Sentiment: None Disclosure: Held
